NTLA
Price
$17.99
Change
+$0.34 (+1.93%)
Updated
Oct 4 closing price
26 days until earnings call
VCYT
Price
$32.84
Change
-$0.13 (-0.39%)
Updated
Oct 4 closing price
31 days until earnings call
Ad is loading...

NTLA vs VCYT

Header iconNTLA vs VCYT Comparison
Open Charts NTLA vs VCYTBanner chart's image
Intellia Therapeutics
Price$17.99
Change+$0.34 (+1.93%)
Volume$1.85M
CapitalizationN/A
Veracyte
Price$32.84
Change-$0.13 (-0.39%)
Volume$377.59K
CapitalizationN/A
View a ticker or compare two or three
NTLA vs VCYT Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NTLA vs. VCYT commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Sell and VCYT is a StrongSell.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (NTLA: $17.99 vs. VCYT: $32.84)
Brand notoriety: NTLA and VCYT are both not notable
NTLA represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NTLA: 136% vs. VCYT: 37%
Market capitalization -- NTLA: $2.13B vs. VCYT: $1.66B
NTLA [@Biotechnology] is valued at $2.13B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 2 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 4 bearish.
  • VCYT’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than VCYT.

Price Growth

NTLA (@Biotechnology) experienced а -14.33% price change this week, while VCYT (@Medical Specialties) price change was -2.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.13%. For the same industry, the average monthly price growth was +4.30%, and the average quarterly price growth was -3.02%.

Reported Earning Dates

NTLA is expected to report earnings on Oct 31, 2024.

VCYT is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-1.13% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.13B) has a higher market cap than VCYT($1.66B). VCYT YTD gains are higher at: 19.375 vs. NTLA (-40.997). VCYT has higher annual earnings (EBITDA): -49.41M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. VCYT (216M). VCYT has less debt than NTLA: VCYT (12.6M) vs NTLA (106M). VCYT has higher revenues than NTLA: VCYT (361M) vs NTLA (46M).
NTLAVCYTNTLA / VCYT
Capitalization2.13B1.66B128%
EBITDA-514.18M-49.41M1,041%
Gain YTD-40.99719.375-212%
P/E RatioN/AN/A-
Revenue46M361M13%
Total Cash691M216M320%
Total Debt106M12.6M841%
FUNDAMENTALS RATINGS
NTLA vs VCYT: Fundamental Ratings
NTLA
VCYT
OUTLOOK RATING
1..100
5975
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
9684
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
8737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (40) in the Biotechnology industry is in the same range as NTLA (42). This means that VCYT’s stock grew similarly to NTLA’s over the last 12 months.

VCYT's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as NTLA (96). This means that VCYT’s stock grew similarly to NTLA’s over the last 12 months.

VCYT's SMR Rating (91) in the Biotechnology industry is in the same range as NTLA (96). This means that VCYT’s stock grew similarly to NTLA’s over the last 12 months.

VCYT's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for NTLA (87). This means that VCYT’s stock grew somewhat faster than NTLA’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NTLA (100). This means that VCYT’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTLAVCYT
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 23 days ago
78%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNRFX84.510.95
+1.14%
Janus Henderson Research D
VAAGX28.860.18
+0.63%
Virtus NFJ Large-Cap Value R6
KNGCX12.790.04
+0.31%
Vest S&P500 Div Aristocrats Trgt Inc C
FEGIX30.42-0.02
-0.07%
First Eagle Gold I
PURZX21.22-0.08
-0.38%
PGIM Global Real Estate Z

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with EDIT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.93%
EDIT - NTLA
75%
Closely correlated
+5.63%
BEAM - NTLA
75%
Closely correlated
+2.05%
CRSP - NTLA
72%
Closely correlated
+1.05%
VCYT - NTLA
69%
Closely correlated
-0.39%
PRME - NTLA
67%
Closely correlated
+2.93%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-0.39%
NTLA - VCYT
69%
Closely correlated
+1.93%
VCEL - VCYT
60%
Loosely correlated
+4.86%
AXON - VCYT
58%
Loosely correlated
+1.63%
DNA - VCYT
57%
Loosely correlated
+2.59%
ABCL - VCYT
55%
Loosely correlated
+0.81%
More